Last updated on August 2016

Effect of Hepatic and Renal Impairment on the Pharmacokinetics Safety and Tolerability of BAY1841788 (ODM-201)


Brief description of study

Evaluate the potential effect of hepatic or renal impairment on the pharmacokinetics, safety and tolerability of BAY 1841788 (ODM-201).

Clinical Study Identifier: NCT02894385

Find a site near you

Start Over

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.